Buy Mirna Therapeutics Stock | MIRN Stock Price & Latest News | Public.com
MIRN

Mirna Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Mirna Therapeutics (MIRN) stock trends here

    About MIRN

    Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded b...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.13
    -0.27
    -0.4
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.40

    Actual EPS
    Q2 2021

    Stats

    Market Cap$132,06M
    Volume124,41k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.11
    1 Year Low$1.74
    Open$3.40
    High$3.45
    Low$3.27

    Buy any stock with any amount of money.

    Download the App
    Download the app